DarioHealth attributes Q2 growth to new approvals, US launches, service offerings

The second quarter of 2018 was a strong one for the rapidly expanding DarioHealth. Touting 70 percent year-over-year revenue growth and a continued decline in its cash burn rate, CEO Erez Raphael credited his company ’s increasing fortune to recent US regulatory approvals and product launches as well as the company’s wider focus on an integrated consumer experience.

Source: mobihealthnews - August 10, 2018 Category: Information Technology Source Type: news